The Impact of COVID-19 on Granted Disability Insurances and Related Costs for Workers With Cancer: A Time Series Study in Brazil.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 39043668.
- Also identified by DOI 10.1097/JOM.0000000000003195.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the impact of the COVID-19 pandemic on disability insurance grants and related costs for workers with cancer. This ecological time series study uses the inflection point regression model and the federal government's open-access dataset. We analyze the annual grant and cost rates of cancer-related disability insurance in Brazil (2010-2021). In 2020, the number of disability insurance grants due to malignant neoplasms decreased by 62.26%, and the total annual cost decreased by 62.94% compared to those in 2019. All illnesses and injuries were reduced by 2.56% and 20.02%, respectively. Between 2010 and 2021, the COVID-19 pandemic has reversed the increasing trend in annual disability insurance granted due to cancer and its associated expenses to a stable trend. The COVID-19 pandemic has harmed the provision of disability insurance for workers with cancer.
Medical subject headings
- COVID-19
- Neoplasms
- Insurance, Disability
- SARS-CoV-2